14. Resistant Starch RS2
Hi-Maize and green banana starch — granular crystallinity, Ruminococcus bromii, and butyrate.
Resistant Starch RS2 in 1 minute
What does it provide? Native B-type crystalline starch — reaches the colon undigested from the small intestine → SCFA + especially butyrate fermentation with the keystone role of Ruminococcus bromii. Insulin sensitivity, postprandial glycemia, body weight benefit in human RCTs.
How much? 20–40 g/day RS2 (Hi-Maize®, raw potato starch, green banana); gradually increase from 5–10 g/day.
When to avoid? Severe IBS flare (transient gas/bloating), severe SIBO, acute diverticulitis, ileus.
Resistant starch's history is not millennia-long, but just over four decades — yet a true scientific revolution: in the supposedly "completely known" basics of nutrition, the century's last big surprise was discovered. The concept was introduced by British Cambridge researchers Hans Englyst and John Cummings in the early 1980s: they noticed that some starches passed through the small intestine without digestion and underwent fermentation in the colon — i.e., they actually behaved "fiber-like." In 1992, Englyst, Kingman, and Cummings published the four-level classification still used today (RS1, RS2, RS3, RS4) — the fifth category (RS5) was added later.[1519] RS2 specifically refers to granules arranged into a compact crystalline structure, which in their natural raw form (raw potato, green banana, high-amylose grains) resist digestion.
High-amylose corn ("amylomaize") was bred by American researchers from the 1940s: H. H. Kramer and colleagues in 1953 identified the recessive gene that raises the amylose content of corn kernels above 50%, whereas in traditional corn this is 25–30%. From the 1990s, the American Ingredion (formerly National Starch) developed the Hi-Maize® brand starch, which became the first widely marketed RS2 ingredient: increasingly popular as a functional fiber source in industrial pastries and gluten-free products. From the 2000s, RS2 has been examined in human RCTs by the Mayo Clinic, Imperial College, Stanford, and many European research centers — and the 2024 Nature article showed body weight reduction in relation to 40 g/day RS2, placing the topic in the front line of nutrition science.[1523]
Scientific Background
RS2 (Resistant Starch type 2) is one type of digestion-resistant starch: native, B-type crystalline starch granules that do not gelatinize in the small intestine due to their compact crystallinity → they reach the colon and ferment there.
Main natural and industrial sources:
- High-amylose corn starch (HAM-RS2 / Hi-Maize®) — > 50% amylose
- Raw potato starch — > 60% RS2 naturally
- Raw green (unripe) banana — > 70% RS2; converts to sugar during ripening
- Some starch concentrates in industrial xylanase-treated products
Ruminococcus bromii is a keystone bacterium — it decisively determines the microbiome's RS2-degrading capacity. R. bromii "primes" starch breakdown, opening access for other microbes (Eubacterium rectale, Faecalibacterium prausnitzii).[1525] A good butyrate response is predicted by R. bromii presence (Walker 2011).[1520]
Human RCT evidence:
- Maki 2012 — HAM-RS2 15 g daily for 4 weeks improved insulin sensitivity in overweight men.[1466]
- Bodinham 2014 (Endocr Connect) — HAM-RS2 gave favorable GLP-1 response in type 2 diabetes.[1522]
- 2024 Nature RCT — 40 g/day RS2 + 8 weeks: body weight loss (≈ −2.8 kg), insulin resistance improvement; microbiota change (R. bromii, Bifidobacterium adolescentis ↑).[1523]
- In older/middle-aged adults, resistant starch intervention modulated microbiota composition.[1526]
Potato-derived RS2 may markedly increase stool butyrate, more than corn-RS2 — due to differences in baseline microbiota and substrate granular structure. Individual variability is significant: there are "responders" (good R. bromii) and "non-responders" (R. bromii deficiency).[1520]
Heat sensitivity: RS2 is lost upon gelatinization (≥ 60–70 °C in moist medium). HAM-RS2 has higher gelatinization temperature, so it withstands baking/extrusion somewhat better — but still decreases under heat. Optimally consumed raw or lightly warmed (cold smoothie, yogurt, oat porridge).
Dosing strategy: start with 5–10 g/day RS2, increase stepwise 10 → 20 → 30 → 40 g/day — transient gas/bloating is expected, which subsides within 2–4 weeks (adaptation).
- + Cold yogurt/smoothie/oat porridge: don't heat RS2 → maximum retention.
- + Live cultures (yogurt, kefir): R. bromii + Bifidobacterium synergy.
- + "Cook-and-chill" RS3 supplementation: potato, rice, pasta cold → broader RS profile.
- + Gradual dose escalation: 5 g/day → +5 g weekly; tolerance improves.
- + Other prebiotic (inulin, FOS, β-glucan): broader SCFA profile.
- + Hydration: mandatory with high fiber intake.
- Too hot food/liquid (≥ 70 °C): gelatinizes RS2 → starch-like digestion.
- Antibiotic + RS2 at the same time (during acute course): microbiota is transiently reduced (little R. bromii) → RS2 fermentation ↓; SCFA advantage decreases.
- Large serving (≥ 30 g) on empty stomach when starting: acute bloating, gas, abdominal discomfort.
- Roasted (ripe, yellow) banana as RS2 source: during ripening RS2 converts to sugar — only raw green banana is effective.
- During severe IBS flare: initially avoid, only gradually in remission phase.
- Severe IBS flare: transient gas/bloating can be severe — start with small portions, or in remission phase.[777]
- Severe SIBO (small intestinal bacterial overgrowth): RS2 fermentation occurs also in the small intestine → exacerbates symptoms.
- Acute diverticulitis, ileus, severe stricture: avoid in acute phase.
- Type 1 diabetes on insulin pump treatment: since RS2 reduces glycemia, insulin dose recalculation needed.
- Severe kidney disease (CKD 4–5): potassium content (especially raw potato starch) — dosing with dietitian.
- Infant (< 12 months): RS2 supplementation not recommended.
Cassava (also called manioc, yuca) is a tropical tuberous plant — a staple food of Latin America, Africa, and Southeast Asia. A daily carbohydrate source for 800 million people. Tapioca (cassava starch) is made from the root and is the second most important industrial RS2 source after high-amylose corn (Hi-Maize®).
Tapioca starch RS2 profile:
- Native, crystalline B-type starch granules
- Amylose content is moderate (15—20%), but a significant portion of the granule structure reaches the colon undigested
- Slower fermentation — lower gas production than Hi-Maize®
- Tapioca pearls ("boba") when cooked have cake-like structure, RS matrix partly retained
Clinical relevance: Pereira 2016 Br J Nutr human pilot — tapioca-derived RS2 30 g/day, 4 weeks: butyrate increase modest, postprandial glucose reduction significant. The clinical evidence base of tapioca is smaller than Hi-Maize®, but in the right direction.
Cassava raw / cooked safety question: RAW cassava contains cyanogenic glycosides (linamarin, lotaustralin) — cooking or fermentation is mandatory. Traditional African method: soak 24 hours + cook + dry → gari or fufu. Commercial tapioca starch is already processed (cyanogenic glycosides removed).
Diet contribution: cassava and tapioca are gluten-free RS sources — celiac-compatible. They can replace wheat flour for thickening, in pancakes, in bread ("pão de queijo" — Brazilian traditional cheese rolls).
FODMAP: green (tapioca starch is essentially pure starch, FODMAP-free). Contraindications: RAW cassava consumption is FORBIDDEN (cyanogenic); diabetes on insulin pump treatment (tapioca starch in a high-glycemic context — can be improved with RS3 transformation via cook-and-chill protocol).
Daily serving
20–40 g RS2/day; on introduction 5–10 g, weekly 5 g increase.
Preparation pattern
- Classic "potato starch smoothie": 1–2 tbsp (5–10 g) raw potato starch into cold water/yogurt/smoothie.
- Green banana smoothie: 1 large green banana + milk/plant milk + chia → breakfast.
- Hi-Maize® oat porridge: 30 g rolled oats + 10 g Hi-Maize® + lukewarm milk (NOT hot!).
- Raw green banana flour: in gluten-free baked goods.
Classic patterns
Tim Steele "bulletproof potato starch": 4 tbsp raw potato starch in yogurt — the popularized RS2 protocol.
Green banana smoothie: 1 green banana + spinach + milk + chia.
Cold RS2 oat porridge: overnight oats + Hi-Maize® + berries.
Modern fusion: chia pudding + RS2 + berries.
Storage and avoidances
Storage: Raw potato starch in an airtight jar in a cool dark place 12 months. Green banana at room temperature stays green for 1–3 days. Hi-Maize® in original packaging 12 months.
What not to do: Don't heat ≥ 70 °C. Don't consume large portions on empty stomach when starting. Don't combine RS2 with acute antibiotic courses.
References
[777] . Monash UniversityMonash FODMAP database. High and Low FODMAP foods. Link
The Monash University FODMAP database, classifying foods as high or low in FODMAP content.
[1466] Maki KC et al. Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men2012;142(4):717–723. J Nutr. Link
This study evaluated the effects of 2 levels of intake of high-amylose maize type 2 resistant starch (HAM-RS2) on insulin sensitivity (S(I)) in participants with waist circumference ≥89 (women) or ≥102 cm (men). Participants received 0 (control starch), 15, or 30 g/d (double-blind) of HAM-RS2 in random order for 4-wk periods separated by 3-wk washouts. Minimal model S(I) was assessed at the end of each period using the insulin-modified i.v. glucose tolerance test. The efficacy evaluable sample included 11 men and 22 women (mean ± SEM) age 49.5 ± 1.6 y, with a BMI of 30.6 ± 0.5 kg/m2 and waist circumference 105.3 ± 1.3 cm. A treatment main effect (P = 0.018) and a treatment × sex interaction (P = 0.033) were present. In men, least squares geometric mean analysis for S(I) did not differ after intake of 15 g/d HAM-RS2 (6.90 × 10⁻⁵ pmol⁻¹ · L⁻¹ × min⁻¹) and 30 g/d HAM-RS2 (7.13 × 10⁻⁵ pmol⁻¹ · L⁻¹ × min⁻¹), but both were higher than after the control treatment (4.66 × 10⁻⁵ pmol⁻¹ · L⁻¹ × min⁻¹) (P < 0.05).
[1519] Englyst HN, Kingman SM, Cummings JH. Classification and measurement of nutritionally important starch fractions1992;46 Suppl 2:S33–S50. Eur J Clin Nutr. Link
For nutritional purposes, starch in foods may be classified into rapidly digestible starch (RDS), slowly digestible starch (SDS) and resistant starch (RS). RS may be further divided into three categories according to the reason for resistance to digestion. A method is reported for the measurement of total starch, RDS, SDS, RS and three RS fractions in starchy foods, using controlled enzymic hydrolysis with pancreatin and amyloglucosidase. The released glucose is measured by colorimetry, using a glucose oxidase kit. Values for RDS and SDS in foods obtained by the method reflect the rate of starch digestion in vivo. Values for RS are similar to the amounts of starch escaping digestion in the small intestine of ileostomates, and are a guide to the amounts of starch likely to enter the colon for fermentation.
[1520] Walker AW et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota2011;5(2):220–230. ISME J. Link
The populations of dominant species within the human colonic microbiota can potentially be modified by dietary intake with consequences for health. Here we examined the influence of precisely controlled diets in 14 overweight men. Volunteers were provided successively with a control diet, diets high in resistant starch (RS) or non-starch polysaccharides (NSPs) and a reduced carbohydrate weight loss (WL) diet, over 10 weeks. Analysis of 16S rRNA sequences in stool samples of six volunteers detected 320 phylotypes (defined at >98\% identity) of which 26, including 19 cultured species, each accounted for >1\% of sequences. Although samples clustered more strongly by individual than by diet, time courses obtained by targeted qPCR revealed that 'blooms' in specific bacterial groups occurred rapidly after a dietary change. These were rapidly reversed by the subsequent diet.
[1522] Bodinham CL et al. Efficacy of increased resistant starch consumption in human type 2 diabetes2014;3(2):75–84. Endocr Connect. Link
Human study (Endocr Connect) on the efficacy of increased resistant starch consumption in human type 2 diabetes.
[1523] Li H et al. Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota2024. Nat Metab. Link
Emerging evidence suggests that modulation of gut microbiota by dietary fibre may offer solutions for metabolic disorders. In a randomized placebo-controlled crossover design trial (ChiCTR-TTRCC-13003333) in 37 participants with overweight or obesity, we test whether resistant starch (RS) as a dietary supplement influences obesity-related outcomes. Here, we show that RS supplementation for 8 weeks can help to achieve weight loss (mean -2.8 kg) and improve insulin resistance in individuals with excess body weight. The benefits of RS are associated with changes in gut microbiota composition. Supplementation with Bifidobacterium adolescentis, a species that is markedly associated with the alleviation of obesity in the study participants, protects male mice from diet-induced obesity. Mechanistically, the RS-induced changes in the gut microbiota alter the bile acid profile, reduce inflammation by restoring the intestinal barrier and inhibit lipid absorption.
[1524] Bendiks ZA et al. Resistant starch type 4 and gut microbiota2020. J Nutr Biochem. Link
Resistant starch type 2 (RS2), a dietary fiber comprised solely of glucose, has been extensively studied in clinical trials and animal models for its capacity to improve metabolic and systemic health. Because the health modulatory effects of RS2 and other dietary fibers are thought to occur through modification of the gut microbiome, those studies frequently include assessments of RS2-mediated changes to intestinal microbial composition and function. In this review, we identify the conserved responses of the gut microbiome among 13 human and 35 animal RS2 intervention studies. Consistent outcomes of RS2 interventions include reductions in bacterial α-diversity; increased production of lumenal short-chain fatty acids; and enrichment of Ruminococcus bromii, Bifidobacterium adolescentis, and other gut taxa. Different taxa are usually responsive in animal models, and many RS2-mediated changes to the gut microbiome vary within and between studies. The root causes for this variation are examined with regard to methodological and analytical differences, host genetics and age, species differences (eg, human, animal), health status, intervention dose and duration, and baseline microbial composition.
[1525] Ze X et al. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon2012. ISME J. Link
The release of energy from particulate substrates such as dietary fiber and resistant starch (RS) in the human colon may depend on the presence of specialist primary degraders (or 'keystone species') within the microbial community. We have explored the roles of four dominant amylolytic bacteria found in the human colon in the degradation and utilization of resistant starches. Eubacterium rectale and Bacteroides thetaiotaomicron showed limited ability to utilize RS2- and RS3-resistant starches by comparison with Bifidobacterium adolescentis and Ruminococcus bromii. In co-culture, however, R. bromii proved unique in stimulating RS2 and RS3 utilization by the other three bacterial species, even in a medium that does not permit growth of R. bromii itself. Having previously demonstrated low RS3 fermentation in vivo in two individuals with undetectable populations of R. bromii-related bacteria, we show here that supplementation of mixed fecal bacteria from one of these volunteers with R. bromii, but not with the other three species, greatly enhanced the extent of RS3 fermentation in vitro. This argues strongly that R. bromii has a pivotal role in fermentation of RS3 in the human large intestine, and that variation in the occurrence of this species and its close relatives may be a primary cause of variable energy recovery from this important component of the diet.
[1526] DeMartino P, Cockburn DW. Resistant starch: impact on the gut microbiome and health2020. Curr Opin Biotechnol. Link
Resistant starch has received a lot of attention for its potential to exert a healthy impact on the gut and certain members of its resident microbiota, particularly through enhanced butyrate production. However, resistant starch is a broad category that encompasses several structurally different starches. While all resist digestion by human enzymes, they differ in their effects on the microbiota. Individual variation in microbiota composition also has a substantial influence on butyrate production. Research on this interaction between resistant starch and the microbiota is using in vitro fermentations, cross-over design clinical trials and mouse studies with isotopically labeled starch. These studies are demonstrating that more personalized approaches are needed for finding resistant starch or other fiber that will promote a healthy gut.